![dpp 4 inhibitor glp 1 agonist DPP-4 inhibitors and GLP-1RAs: cardiovascular safety and benefits | Military Medical Research dpp-4_inhibitors [TUSOM | Pharmwiki]](https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs40779-022-00410-2/MediaObjects/40779_2022_410_Fig1_HTML.png)
dpp 4 inhibitor glp 1 agonist DPP-4 inhibitors and GLP-1RAs: cardiovascular safety and benefits | Military Medical Research dpp-4_inhibitors [TUSOM | Pharmwiki]
Description
Diagnostics (Basel, Switzerland) 15 , 580 (2025)
![dpp 4 inhibitor glp 1 agonist DPP-4 inhibitors and GLP-1RAs: cardiovascular safety and benefits | Military Medical Research dpp-4_inhibitors [TUSOM | Pharmwiki]](https://tmedweb.tulane.edu/pharmwiki/lib/exe/fetch.php/dpp4.png?w=600&tok=f9724b)
27.Wilding JPH, Batterham RL, Calanna S, et al
![dpp 4 inhibitor glp 1 agonist DPP-4 inhibitors and GLP-1RAs: cardiovascular safety and benefits | Military Medical Research dpp-4_inhibitors [TUSOM | Pharmwiki]](https://ars.els-cdn.com/content/image/1-s2.0-S0085253821010656-fx1.jpg)
5 But, when CPZ doses were properly controlled, the NLY01 was no longer effective in reducing demyelination or improving remyelination
![dpp 4 inhibitor glp 1 agonist DPP-4 inhibitors and GLP-1RAs: cardiovascular safety and benefits | Military Medical Research dpp-4_inhibitors [TUSOM | Pharmwiki]](https://www.mclaren.org/Uploads/Public/Images/MPHO/ClinicalCorner_20210615_GLP_1.jpg)
doi: 10.1016/j.peptides.2017.11.023
![dpp 4 inhibitor glp 1 agonist DPP-4 inhibitors and GLP-1RAs: cardiovascular safety and benefits | Military Medical Research dpp-4_inhibitors [TUSOM | Pharmwiki]](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1f6/9392232/8bcb7af02d5c/40779_2022_410_Fig2_HTML.jpg)
C., et al
![dpp 4 inhibitor glp 1 agonist DPP-4 inhibitors and GLP-1RAs: cardiovascular safety and benefits | Military Medical Research dpp-4_inhibitors [TUSOM | Pharmwiki]](https://www.uspharmacist.com/CMSImagesContent/2007/10/10_DPP-4-T1.jpg)
During physical activity, elevated IL-6 levels can slow gastric motility, contributing to enhanced postprandial satiety and improved glycemic control
![dpp 4 inhibitor glp 1 agonist DPP-4 inhibitors and GLP-1RAs: cardiovascular safety and benefits | Military Medical Research dpp-4_inhibitors [TUSOM | Pharmwiki]](https://figures.semanticscholar.org/10b9e57d49ea4628324390cde4d3e80d0a5562fd/2-Figure1-1.png)
